Cost-effectiveness of Multidisciplinary Interventions for Chronic Low Back Pain: A Narrative Review.
Journal
The Clinical journal of pain
ISSN: 1536-5409
Titre abrégé: Clin J Pain
Pays: United States
ID NLM: 8507389
Informations de publication
Date de publication:
22 11 2021
22 11 2021
Historique:
received:
29
08
2020
accepted:
09
11
2021
pubmed:
24
11
2021
medline:
3
5
2022
entrez:
23
11
2021
Statut:
epublish
Résumé
Chronic musculoskeletal pain in adults is a global health and economic problem. The aim of this paper was to systematically review and determine what proportion of multidisciplinary approaches to managing chronic musculoskeletal pain are cost-effective. The EconLit, Embase, and PubMed electronic databases were searched for randomized and nonrandomized economic evaluation studies of nonpharmaceutical multidisciplinary chronic pain management interventions published from inception through to August 2019. Seven studies comprising 2095 patients were included. All studies involved diverse multidisciplinary teams in one or more of the study arms. All studies involved chronic (both chronic and subacute) low back pain and were economic evaluations from either a societal or health care perspective. Two of the 3 studies that reported on a multidisciplinary pain intervention compared with nonmultidisciplinary intervention concluded favorable cost-effectiveness based on cost per quality adjusted life years gained, 1 study was not found to be cost-effective. Cost-effectiveness of the multidisciplinary intervention of interest was also not established by another 3-arm study. Two studies compared 2 multidisciplinary interventions; neither of these could definitively declare cost-effectiveness. The remaining study indicated the intervention by a multidisciplinary team was more effective but at a higher cost. None of the included studies used decision models to estimate long-term health outcomes and cost-effectiveness of multidisciplinary programs. There are few studies on the cost-effectiveness of multidisciplinary chronic pain management interventions. This study encourages additional rigorous economic evaluations of multidisciplinary models for chronic pain management. Economic evaluations that enable extrapolating costs and effects of multidisciplinary programs beyond the time horizon of clinical trials may be more informative for clinicians and health administrators.
Identifiants
pubmed: 34812772
doi: 10.1097/AJP.0000000000001009
pii: 00002508-202203000-00006
pmc: PMC8823904
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
197-207Informations de copyright
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Global Burden of Disease 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858.
Fayaz A, Croft P, Langford RM, et al. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open. 2016;6:e010364.
Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. J Pain. 2015;16:769–780.
Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012;13:715–724.
Schofield DJ, Shrestha RN, Percival R, et al. The personal and national costs of early retirement because of spinal disorders: impacts on income, taxes, and government support payments. Spine J. 2012;12:1111–1118.
Schofield DJ, Shrestha RN, Percival R, et al. Early retirement and the financial assets of individuals with back problems. Eur Spine J. 2011;20:731–736.
Deloitte Access Economics. The cost of pain in Australia. 2019. Available at: https://www.painaustralia.org.au/static/uploads/files/the-cost-of-pain-in-australia-final-report-12mar-wfxbrfyboams.pdf . Accessed August 21, 2019.
Chou R, Deyo R, Friedly J, et al. Nonpharmacologic therapies for low back pain: a systematic review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017;166:493–505.
Kamper SJ, Apeldoorn AT, Chiarotto A, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ. 2015;350:h444.
Banerjee S, Argáez C. Multidisciplinary treatment programs for patients with chronic non-malignant pain: a review of clinical effectiveness, cost-effectiveness, and guidelines. 2017. Available at: https://www.ncbi.nlm.nih.gov/books/NBK525038/ . Accessed August 22, 2019.
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315:1624–1645.
Turk DC, Wilson HD, Cahana A. Treatment of chronic non-cancer pain. Lancet. 2011;377:2226–2235.
Karjalainen K, Malmivaara A, van Tulder M, et al. Multidisciplinary biopsychosocial rehabilitation for neck and shoulder pain among working age adults: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine (Phila Pa 1976). 2001;26:174–181.
Thomsen AB, Sorensen J, Sjogren P, et al. Economic evaluation of multidisciplinary pain management in chronic pain patients: a qualitative systematic review. J Pain Symptom Manage. 2001;22:688–698.
Nicholas MK, Asghari A, Corbett M, et al. Is adherence to pain self-management strategies associated with improved pain, depression and disability in those with disabling chronic pain? Eur J Pain. 2012;16:93–104.
Clark VP, Parasuraman R. Neuroenhancement: enhancing brain and mind in health and in disease. NeuroImage. 2014;85:889–894.
International Association for the Study of Pain (IASP). Pain treatment services. Available at: https://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1381 . Accessed August 21, 2019.
Grant SJ, Frawley J, Bensoussan A. Process of care in outpatient integrative healthcare facilities: a systematic review of clinical trials. BMC Health Serv Res. 2015;15:322.
Xie F, Tanvejsilp P, Campbell K, et al. Cost-effectiveness of pharmaceutical management for osteoarthritis pain: a systematic review of the literature and recommendations for future economic evaluation. Drugs Aging. 2013;30:277–284.
Salathe CR, Melloh M, Crawford R, et al. Treatment efficacy, clinical utility, and cost-effectiveness of multidisciplinary biopsychosocial rehabilitation treatments for persistent low back pain: a systematic review. Global Spine J. 2018;8:872–886.
Freyd M. The graphic rating scale. J Educ Psychol. 1923;14:83–102.
Heller GZ, Manuguerra M, Chow R. How to analyze the Visual Analogue Scale: myths, truths and clinical relevance. Scand J Pain. 2016;13:67–75.
Dunn KM, Croft PR. Classification of low back pain in primary care: using “bothersomeness” to identify the most severe cases. Spine (Phila Pa 1976). 2005;30:1887–1892.
Cherkin DC, Sherman KJ, Balderson BH, et al. Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial. JAMA. 2016;315:1240–1249.
Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233.
McCaffrey N, Kaambwa B, Currow DC, et al. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms. Health Qual Life Outcomes. 2016;14:133.
Waddell G, Newton M, Henderson I, et al. A Fear-Avoidance Beliefs Questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic low back pain and disability. Pain. 1993;52:157–168.
Nicholas MK. The Pain Self-Efficacy Questionnaire: taking pain into account. Eur J Pain. 2007;11:153–163.
Roland M, Morris R. A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine (Phila Pa 1976). 1983;8:141–144.
Kopec JA, Esdaile JM, Abrahamowicz M, et al. The Quebec Back Pain Disability Scale. Measurement properties. Spine (Phila Pa 1976). 1995;20:341–352.
Kopec JA, Esdaile JM, Abrahamowicz M, et al. The Quebec Back Pain Disability Scale: conceptualization and development. J Clin Epidemiol. 1996;49:151–161.
Nymark L, Vassall A. A comprehensive framework for considering additional unintended consequences in economic evaluation. Cost Eff Resour Alloc. 2020;18:27.
Kim N, Yang B, Lee T, et al. An economic analysis of usual care and acupuncture collaborative treatment on chronic low back pain: a Markov model decision analysis. BMC Complement Altern Med. 2010;10:74.
Drummond M, Sculpher MJ, Claxton K, et al. Methods for the Economic Evaluation of Health Care Programmes. Oxford, UK: Oxford University Press; 2015.
Viswanathan M, Ansari MT, Berkman ND, et al. Assessing the risk of bias of individual studies in systematic reviews of health care interventions. 2012. Available at: https://effectivehealthcare.ahrq.gov/products/methods-guidance-bias-individual-studies/methods . Accessed August 22, 2019.
Goossens ME, de Kinderen RJ, Leeuw M, et al. Is exposure in vivo cost-effective for chronic low back pain? A trial-based economic evaluation. BMC Health Serv Res. 2015;15:549.
Jensen C, Nielsen CV, Jensen OK, et al. Cost-effectiveness and cost-benefit analyses of a multidisciplinary intervention compared with a brief intervention to facilitate return to work in sick-listed patients with low back pain. Spine (Phila Pa 1976). 2013;38:1059–1067.
Lamb SE, Lall R, Hansen Z, et al. A multicentred randomised controlled trial of a primary care-based cognitive behavioural programme for low back pain. The Back Skills Training (BeST) trial. Health Technol Assess. 2010;14:1–253; iii–iv.
Lambeek LC, Bosmans JE, Van Royen BJ, et al. Effect of integrated care for sick listed patients with chronic low back pain: economic evaluation alongside a randomised controlled trial. BMJ. 2010;341:c6414.
Schweikert B, Jacobi E, Seitz R, et al. Effectiveness and cost-effectiveness of adding a cognitive behavioral treatment to the rehabilitation of chronic low back pain. J Rheumatol. 2006;33:2519–2526.
Smeets RJ, Severens JL, Beelen S, et al. More is not always better: cost-effectiveness analysis of combined, single behavioral and single physical rehabilitation programs for chronic low back pain. Eur J Pain. 2009;13:71–81.
Wayne PM, Buring JE, Eisenberg DM, et al. Cost-effectiveness of a team-based integrative medicine approach to the treatment of back pain. J Altern Complement Med. 2019;25:S138–S146.
Leeuw M, Goossens ME, van Breukelen GJ, et al. Exposure in vivo versus operant graded activity in chronic low back pain patients: results of a randomized controlled trial. Pain. 2008;138:192–207.
Lambeek LC, Anema JR, Van Royen BJ, et al. Multidisciplinary outpatient care program for patients with chronic low back pain: design of a randomized controlled trial and cost-effectiveness study [ISRCTN28478651]. BMC Public Health. 2007;7:254.
Jensen IB, Busch H, Bodin L, et al. Cost effectiveness of two rehabilitation programmes for neck and back pain patients: a seven year follow-up. Pain. 2009;142:202–208.
Jensen C, Jensen OK, Christiansen DH, et al. One-year follow-up in employees sick-listed because of low back pain: randomized clinical trial comparing multidisciplinary and brief intervention. Spine (Phila Pa 1976). 2011;36:1180–1189.
Wayne PM, Eisenberg DM, Osypiuk K, et al. A multidisciplinary integrative medicine team in the treatment of chronic low-back pain: an observational comparative effectiveness study. J Altern Complement Med. 2018;24:781–791.
Edmunds K, Ling R, Shakeshaft A, et al. Systematic review of economic evaluations of interventions for high risk young people. BMC Health Serv Res. 2018;18:660.
Chuang LH, Soares MO, Tilbrook H, et al. A pragmatic multicentered randomized controlled trial of yoga for chronic low back pain: economic evaluation. Spine (Phila Pa 1976). 2012;37:1593–1601.